Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BAXTER INTERNATIONAL INC Director's Dealing 2015

Jul 7, 2015

30537_dirs_2015-07-06_ea4ac2a8-e4cd-41de-b28d-1ea7e6db2f70.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BAXTER INTERNATIONAL INC (BAX)
CIK: 0000010456
Period of Report: 2015-07-01

Reporting Person: Bufalino Sebastian J (CVP, Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-07-01 Common Stock, par value $1.00 per share J 2840 $0.00 Acquired 19042 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-07-01 Stock Option (Right to Buy) $37.38 J 21356 Acquired 2025-03-03 Common Stock, par value $1.00 per share (21356) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $27.58 2017-03-15 Common Stock, par value $1.00 per share (10000) 10000 Direct
Stock Option (Right to Buy) $31.30 2018-03-05 Common Stock, par value $1.00 per share (8000) 8000 Direct
Stock Option (Right to Buy) $28.27 2019-03-04 Common Stock, par value $1.00 per share (7800) 7800 Direct
Stock Option (Right to Buy) $31.77 2020-03-03 Common Stock, par value $1.00 per share (9218) 9218 Direct
Stock Option (Right to Buy) $28.97 2021-03-04 Common Stock, par value $1.00 per share (10753) 10753 Direct
Stock Option (Right to Buy) $30.95 2022-03-06 Common Stock, par value $1.00 per share (11075) 11075 Direct
Stock Option (Right to Buy) $37.82 2023-03-05 Common Stock, par value $1.00 per share (15860) 15860 Direct
Stock Option (Right to Buy) $37.17 2024-03-04 Common Stock, par value $1.00 per share (19347) 19347 Direct

Footnotes

F1: In connection with the spin-off (the "Spin-off") of Baxalta Incorporated ("Baxalta") from Baxter International Inc. ("Baxter"), the reporting person received a grant of 2,840 restricted stock units as a result of the adjustment of existing Baxter restricted stock units held by the reporting person prior to the Spin-off. These restricted stock units will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date.

F2: Represents options to purchase Baxter common stock awarded to the reporting person prior to the Spin-off. In connection with the Spin-off, the exercise price of the option was adjusted, and the reporting person received options to purchase shares of Baxalta common stock, to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.

F3: This option is presently exercisable in full.

F4: Two-thirds of this option is presently exercisable. The remaining one third becomes exercisable on March 5, 2016.

F5: One-third of this option is presently exercisable. The remaining two thirds become exercisable on March 4, 2016 and March 4, 2017.

F6: In connection with the Spin-off, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.

F7: This option will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date of the existing option award.